GO:0050847 | progesterone receptor signaling pathway | 5.95e-05 | 5.81e-01 | 7.347 | 2 | 2 | 6 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.17e-04 | 1.00e+00 | 6.472 | 2 | 4 | 11 |
GO:0004832 | valine-tRNA ligase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:1901673 | regulation of spindle assembly involved in mitosis | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0043578 | nuclear matrix organization | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0010965 | regulation of mitotic sister chromatid separation | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0006404 | RNA import into nucleus | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0031453 | positive regulation of heterochromatin assembly | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0097363 | protein O-GlcNAc transferase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0016262 | protein N-acetylglucosaminyltransferase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0046626 | regulation of insulin receptor signaling pathway | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0000189 | MAPK import into nucleus | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0031990 | mRNA export from nucleus in response to heat stress | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0042306 | regulation of protein import into nucleus | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0070840 | dynein complex binding | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0046832 | negative regulation of RNA export from nucleus | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0004842 | ubiquitin-protein transferase activity | 5.49e-03 | 1.00e+00 | 3.033 | 3 | 17 | 179 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 3 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:1901315 | negative regulation of histone H2A K63-linked ubiquitination | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 3 |
GO:0006405 | RNA export from nucleus | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0010793 | regulation of mRNA export from nucleus | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0045292 | mRNA cis splicing, via spliceosome | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 4 |
GO:0006999 | nuclear pore organization | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0006110 | regulation of glycolytic process | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0061087 | positive regulation of histone H3-K27 methylation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0070849 | response to epidermal growth factor | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0044615 | nuclear pore nuclear basket | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0005739 | mitochondrion | 9.13e-03 | 1.00e+00 | 1.889 | 5 | 32 | 659 |
GO:0046825 | regulation of protein export from nucleus | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:2000780 | negative regulation of double-strand break repair | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 5 |
GO:0035020 | regulation of Rac protein signal transduction | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0043495 | protein anchor | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0005515 | protein binding | 1.13e-02 | 1.00e+00 | 0.729 | 14 | 198 | 4124 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 6 |
GO:0030854 | positive regulation of granulocyte differentiation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 6 |
GO:0070688 | MLL5-L complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 6 |
GO:0080182 | histone H3-K4 trimethylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 6 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.26e-02 | 1.00e+00 | 3.539 | 2 | 5 | 84 |
GO:0005634 | nucleus | 1.26e-02 | 1.00e+00 | 0.852 | 12 | 158 | 3246 |
GO:0003723 | RNA binding | 1.33e-02 | 1.00e+00 | 2.568 | 3 | 22 | 247 |
GO:0002199 | zona pellucida receptor complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 4 | 7 |
GO:0043981 | histone H4-K5 acetylation | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 7 |
GO:0043982 | histone H4-K8 acetylation | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0000339 | RNA cap binding | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 4 | 7 |
GO:0005868 | cytoplasmic dynein complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0034450 | ubiquitin-ubiquitin ligase activity | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0000209 | protein polyubiquitination | 1.49e-02 | 1.00e+00 | 3.408 | 2 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.49e-02 | 1.00e+00 | 3.408 | 2 | 6 | 92 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0005845 | mRNA cap binding complex | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0045667 | regulation of osteoblast differentiation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 8 |
GO:0042405 | nuclear inclusion body | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0008375 | acetylglucosaminyltransferase activity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0051292 | nuclear pore complex assembly | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 4 | 8 |
GO:0006450 | regulation of translational fidelity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0043984 | histone H4-K16 acetylation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0000123 | histone acetyltransferase complex | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 4 | 8 |
GO:0006493 | protein O-linked glycosylation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0035457 | cellular response to interferon-alpha | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0010225 | response to UV-C | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 9 |
GO:0019789 | SUMO ligase activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 9 |
GO:0006379 | mRNA cleavage | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 9 |
GO:0045947 | negative regulation of translational initiation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 9 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 10 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 10 |
GO:0010467 | gene expression | 2.14e-02 | 1.00e+00 | 1.868 | 4 | 49 | 535 |
GO:0051019 | mitogen-activated protein kinase binding | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 11 |
GO:0090316 | positive regulation of intracellular protein transport | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 11 |
GO:0045807 | positive regulation of endocytosis | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 11 |
GO:0005487 | nucleocytoplasmic transporter activity | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 11 |
GO:0046827 | positive regulation of protein export from nucleus | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 11 |
GO:0042307 | positive regulation of protein import into nucleus | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 3 | 12 |
GO:0034399 | nuclear periphery | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 3 | 12 |
GO:0016575 | histone deacetylation | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 14 |
GO:0005654 | nucleoplasm | 2.85e-02 | 1.00e+00 | 1.479 | 5 | 68 | 876 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 15 |
GO:0030864 | cortical actin cytoskeleton | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 1 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 16 |
GO:0045862 | positive regulation of proteolysis | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 3 | 17 |
GO:0016874 | ligase activity | 3.54e-02 | 1.00e+00 | 2.742 | 2 | 11 | 146 |
GO:0006611 | protein export from nucleus | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 1 | 18 |
GO:0031047 | gene silencing by RNA | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 18 |
GO:0031397 | negative regulation of protein ubiquitination | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 18 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 19 |
GO:0015631 | tubulin binding | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 1 | 20 |
GO:0006913 | nucleocytoplasmic transport | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 20 |
GO:0072686 | mitotic spindle | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 1 | 20 |
GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 21 |
GO:0031647 | regulation of protein stability | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 21 |
GO:0006606 | protein import into nucleus | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 3 | 22 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 3 | 22 |
GO:0016925 | protein sumoylation | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 3 | 22 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 1 | 22 |
GO:0034605 | cellular response to heat | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 1 | 22 |
GO:0016071 | mRNA metabolic process | 4.66e-02 | 1.00e+00 | 2.522 | 2 | 10 | 170 |
GO:0007162 | negative regulation of cell adhesion | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 6 | 24 |
GO:0016592 | mediator complex | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 6 | 25 |
GO:0010827 | regulation of glucose transport | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 7 | 25 |
GO:0007094 | mitotic spindle assembly checkpoint | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 4 | 25 |
GO:0009267 | cellular response to starvation | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 1 | 26 |
GO:0003713 | transcription coactivator activity | 5.37e-02 | 1.00e+00 | 2.408 | 2 | 21 | 184 |
GO:0008047 | enzyme activator activity | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 27 |
GO:0006355 | regulation of transcription, DNA-templated | 5.39e-02 | 1.00e+00 | 1.450 | 4 | 31 | 715 |
GO:0016070 | RNA metabolic process | 5.58e-02 | 1.00e+00 | 2.377 | 2 | 10 | 188 |
GO:0031072 | heat shock protein binding | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 1 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 4 | 29 |
GO:0006446 | regulation of translational initiation | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 2 | 29 |
GO:0043130 | ubiquitin binding | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 3 | 30 |
GO:0019898 | extrinsic component of membrane | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 1 | 30 |
GO:0050681 | androgen receptor binding | 5.97e-02 | 1.00e+00 | 4.025 | 1 | 2 | 30 |
GO:0007077 | mitotic nuclear envelope disassembly | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 9 | 32 |
GO:0071300 | cellular response to retinoic acid | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 1 | 32 |
GO:0006281 | DNA repair | 6.39e-02 | 1.00e+00 | 2.266 | 2 | 24 | 203 |
GO:0007254 | JNK cascade | 6.74e-02 | 1.00e+00 | 3.844 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 5 | 35 |
GO:0030521 | androgen receptor signaling pathway | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 3 | 35 |
GO:0031124 | mRNA 3'-end processing | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 4 | 35 |
GO:0044297 | cell body | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 5 | 35 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 2 | 36 |
GO:0008645 | hexose transport | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 8 | 36 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 7.32e-02 | 1.00e+00 | 3.722 | 1 | 2 | 37 |
GO:0003743 | translation initiation factor activity | 7.32e-02 | 1.00e+00 | 3.722 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.51e-02 | 1.00e+00 | 3.684 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 7.51e-02 | 1.00e+00 | 3.684 | 1 | 5 | 38 |
GO:0044822 | poly(A) RNA binding | 7.53e-02 | 1.00e+00 | 1.289 | 4 | 45 | 799 |
GO:0032868 | response to insulin | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 1 | 39 |
GO:0019827 | stem cell maintenance | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 4 | 39 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 4 | 40 |
GO:0016787 | hydrolase activity | 7.89e-02 | 1.00e+00 | 3.610 | 1 | 3 | 40 |
GO:0032922 | circadian regulation of gene expression | 8.08e-02 | 1.00e+00 | 3.574 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 8.08e-02 | 1.00e+00 | 3.574 | 1 | 1 | 41 |
GO:0007584 | response to nutrient | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 1 | 44 |
GO:0006406 | mRNA export from nucleus | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 7 | 44 |
GO:0043085 | positive regulation of catalytic activity | 8.83e-02 | 1.00e+00 | 3.440 | 1 | 2 | 45 |
GO:0015758 | glucose transport | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 8 | 48 |
GO:0000151 | ubiquitin ligase complex | 9.39e-02 | 1.00e+00 | 3.347 | 1 | 4 | 48 |
GO:0005643 | nuclear pore | 9.95e-02 | 1.00e+00 | 3.259 | 1 | 12 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.01e-01 | 1.00e+00 | 3.231 | 1 | 8 | 52 |
GO:0000776 | kinetochore | 1.07e-01 | 1.00e+00 | 3.150 | 1 | 8 | 55 |
GO:0008584 | male gonad development | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 1 | 57 |
GO:0003729 | mRNA binding | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 4 | 57 |
GO:0003697 | single-stranded DNA binding | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 4 | 57 |
GO:0042826 | histone deacetylase binding | 1.12e-01 | 1.00e+00 | 3.073 | 1 | 5 | 58 |
GO:0006464 | cellular protein modification process | 1.18e-01 | 1.00e+00 | 3.001 | 1 | 4 | 61 |
GO:0016337 | single organismal cell-cell adhesion | 1.20e-01 | 1.00e+00 | 2.977 | 1 | 3 | 62 |
GO:0030018 | Z disc | 1.23e-01 | 1.00e+00 | 2.931 | 1 | 3 | 64 |
GO:0030308 | negative regulation of cell growth | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 3 | 70 |
GO:0006325 | chromatin organization | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 4 | 70 |
GO:0051082 | unfolded protein binding | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 5 | 70 |
GO:0001649 | osteoblast differentiation | 1.41e-01 | 1.00e+00 | 2.722 | 1 | 5 | 74 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.41e-01 | 1.00e+00 | 1.186 | 3 | 29 | 644 |
GO:0005737 | cytoplasm | 1.44e-01 | 1.00e+00 | 0.569 | 8 | 127 | 2633 |
GO:0005829 | cytosol | 1.44e-01 | 1.00e+00 | 0.713 | 6 | 88 | 1787 |
GO:0005815 | microtubule organizing center | 1.47e-01 | 1.00e+00 | 2.665 | 1 | 4 | 77 |
GO:0016605 | PML body | 1.50e-01 | 1.00e+00 | 2.628 | 1 | 5 | 79 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.53e-01 | 1.00e+00 | 1.518 | 2 | 23 | 341 |
GO:0030529 | ribonucleoprotein complex | 1.55e-01 | 1.00e+00 | 2.574 | 1 | 5 | 82 |
GO:0005215 | transporter activity | 1.55e-01 | 1.00e+00 | 2.574 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.57e-01 | 1.00e+00 | 2.556 | 1 | 2 | 83 |
GO:0005635 | nuclear envelope | 1.57e-01 | 1.00e+00 | 2.556 | 1 | 6 | 83 |
GO:0044267 | cellular protein metabolic process | 1.61e-01 | 1.00e+00 | 1.472 | 2 | 14 | 352 |
GO:0042802 | identical protein binding | 1.63e-01 | 1.00e+00 | 1.464 | 2 | 15 | 354 |
GO:0006351 | transcription, DNA-templated | 1.72e-01 | 1.00e+00 | 0.860 | 4 | 47 | 1076 |
GO:0006260 | DNA replication | 1.76e-01 | 1.00e+00 | 2.377 | 1 | 9 | 94 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.79e-01 | 1.00e+00 | 1.373 | 2 | 21 | 377 |
GO:0006457 | protein folding | 1.81e-01 | 1.00e+00 | 2.332 | 1 | 5 | 97 |
GO:0008270 | zinc ion binding | 1.83e-01 | 1.00e+00 | 1.011 | 3 | 39 | 727 |
GO:0006413 | translational initiation | 1.85e-01 | 1.00e+00 | 2.302 | 1 | 6 | 99 |
GO:0030335 | positive regulation of cell migration | 1.88e-01 | 1.00e+00 | 2.273 | 1 | 2 | 101 |
GO:0010628 | positive regulation of gene expression | 1.96e-01 | 1.00e+00 | 2.204 | 1 | 2 | 106 |
GO:0042981 | regulation of apoptotic process | 2.06e-01 | 1.00e+00 | 2.124 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 2.11e-01 | 1.00e+00 | 2.086 | 1 | 8 | 115 |
GO:0016032 | viral process | 2.18e-01 | 1.00e+00 | 1.190 | 2 | 30 | 428 |
GO:0006974 | cellular response to DNA damage stimulus | 2.21e-01 | 1.00e+00 | 2.013 | 1 | 11 | 121 |
GO:0016607 | nuclear speck | 2.23e-01 | 1.00e+00 | 2.001 | 1 | 8 | 122 |
GO:0016020 | membrane | 2.28e-01 | 1.00e+00 | 0.694 | 4 | 56 | 1207 |
GO:0000398 | mRNA splicing, via spliceosome | 2.32e-01 | 1.00e+00 | 1.931 | 1 | 15 | 128 |
GO:0005730 | nucleolus | 2.33e-01 | 1.00e+00 | 0.682 | 4 | 74 | 1217 |
GO:0031965 | nuclear membrane | 2.35e-01 | 1.00e+00 | 1.909 | 1 | 8 | 130 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.39e-01 | 1.00e+00 | 1.099 | 2 | 29 | 456 |
GO:0031625 | ubiquitin protein ligase binding | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 7 | 138 |
GO:0044212 | transcription regulatory region DNA binding | 2.56e-01 | 1.00e+00 | 1.772 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 2.73e-01 | 1.00e+00 | 1.665 | 1 | 7 | 154 |
GO:0005874 | microtubule | 2.86e-01 | 1.00e+00 | 1.583 | 1 | 10 | 163 |
GO:0008380 | RNA splicing | 2.89e-01 | 1.00e+00 | 1.565 | 1 | 21 | 165 |
GO:0007067 | mitotic nuclear division | 2.89e-01 | 1.00e+00 | 1.565 | 1 | 9 | 165 |
GO:0046872 | metal ion binding | 2.98e-01 | 1.00e+00 | 0.649 | 3 | 24 | 934 |
GO:0019221 | cytokine-mediated signaling pathway | 2.99e-01 | 1.00e+00 | 1.505 | 1 | 10 | 172 |
GO:0006412 | translation | 3.08e-01 | 1.00e+00 | 1.456 | 1 | 12 | 178 |
GO:0003779 | actin binding | 3.10e-01 | 1.00e+00 | 1.448 | 1 | 3 | 179 |
GO:0005975 | carbohydrate metabolic process | 3.20e-01 | 1.00e+00 | 1.392 | 1 | 10 | 186 |
GO:0016567 | protein ubiquitination | 3.22e-01 | 1.00e+00 | 1.377 | 1 | 14 | 188 |
GO:0005743 | mitochondrial inner membrane | 3.35e-01 | 1.00e+00 | 1.309 | 1 | 9 | 197 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.37e-01 | 1.00e+00 | 0.747 | 2 | 22 | 582 |
GO:0019899 | enzyme binding | 3.53e-01 | 1.00e+00 | 1.217 | 1 | 7 | 210 |
GO:0007165 | signal transduction | 3.64e-01 | 1.00e+00 | 0.660 | 2 | 24 | 618 |
GO:0043231 | intracellular membrane-bounded organelle | 3.64e-01 | 1.00e+00 | 1.163 | 1 | 8 | 218 |
GO:0008283 | cell proliferation | 3.91e-01 | 1.00e+00 | 1.031 | 1 | 8 | 239 |
GO:0003682 | chromatin binding | 4.08e-01 | 1.00e+00 | 0.954 | 1 | 15 | 252 |
GO:0043565 | sequence-specific DNA binding | 4.36e-01 | 1.00e+00 | 0.828 | 1 | 8 | 275 |
GO:0008285 | negative regulation of cell proliferation | 4.38e-01 | 1.00e+00 | 0.818 | 1 | 11 | 277 |
GO:0000278 | mitotic cell cycle | 4.80e-01 | 1.00e+00 | 0.637 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.84e-01 | 1.00e+00 | 0.623 | 1 | 17 | 317 |
GO:0055085 | transmembrane transport | 4.96e-01 | 1.00e+00 | 0.570 | 1 | 13 | 329 |
GO:0005524 | ATP binding | 5.57e-01 | 1.00e+00 | 0.131 | 2 | 37 | 892 |
GO:0006915 | apoptotic process | 5.77e-01 | 1.00e+00 | 0.248 | 1 | 15 | 411 |
GO:0003677 | DNA binding | 5.91e-01 | 1.00e+00 | 0.044 | 2 | 52 | 947 |
GO:0042803 | protein homodimerization activity | 5.92e-01 | 1.00e+00 | 0.190 | 1 | 13 | 428 |
GO:0005887 | integral component of plasma membrane | 7.03e-01 | 1.00e+00 | -0.236 | 1 | 8 | 575 |
GO:0044281 | small molecule metabolic process | 8.36e-01 | 1.00e+00 | -0.790 | 1 | 35 | 844 |
GO:0070062 | extracellular vesicular exosome | 8.73e-01 | 1.00e+00 | -0.749 | 2 | 51 | 1641 |
GO:0005886 | plasma membrane | 9.03e-01 | 1.00e+00 | -0.869 | 2 | 46 | 1784 |